Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    No phase data available

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(1)
    Other(2)

    Detailed Status

    unknown2
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%

    Trials by Status

    completed133%
    unknown267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    unknown

    The RIsk Stratification in COVID-19 Patients in the ICU Registry

    NCT04357275
    completed

    Survival Rates and Longterm Outcomes After COVID-19

    NCT04601090
    unknown

    Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis

    NCT04032743

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT04357275

    The RIsk Stratification in COVID-19 Patients in the ICU Registry

    Unknown
    NCT04601090

    Survival Rates and Longterm Outcomes After COVID-19

    Completed
    NCT04032743

    Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis

    Unknown

    All 3 trials loaded

    Drug Details

    Intervention Type
    Other
    Total Trials
    3